12 | $OTLK Hod1.61 f23.655M | znewcar1 | 12/26/2024 12:36:06 PM |
11 | OTLK 21% v25,6M c1.79 f162M H1.85 morning pop got | znewcar1 | 02/04/2021 6:15:59 PM |
10 | OTLK 27% v28,8M c1.47 f127M H1.65 got S@1.35 | znewcar1 | 02/03/2021 5:35:16 PM |
9 | OTLK 20% v6,6M c1.050 f91,3M H1.09 | znewcar1 | 05/27/2020 4:59:40 PM |
8 | OTLK 48% v6,0M c.875 f38M late day BO over .65 | znewcar1 | 01/02/2020 7:46:38 PM |
7 | OTLK 53% v6,1M c1.59 f28,M H 1.74 After hour gap | znewcar1 | 12/03/2019 4:15:47 PM |
6 | OTLK 21% v1,3M c1.60 f28M H1.85 | znewcar1 | 08/28/2019 4:49:22 PM |
5 | OTLK 34% v28K c2.63 f22M H 2.89 gapup@2.2 S@2.1 | znewcar1 | 07/18/2019 9:20:06 PM |
4 | OTLK 20% v4,3M c2.32 f22M morning rocket with a a | znewcar1 | 06/14/2019 4:33:17 PM |
3 | OTLK 42% v25,5M c2.79 f22M H 2.89 gap up hit 2.6 | znewcar1 | 05/24/2019 4:09:43 PM |
2 | OTLK 42% v52M c3.00 f22M Another gap and | znewcar1 | 05/20/2019 11:33:10 PM |
1 | 24.27% v2,333,163 c1.2800 f85,091,062 morning | znewcar1 | 02/14/2019 4:31:13 PM |
Recent Articles
- Replimune Group's Stock Drop Sparks Investor Class Action Suit
- Investing in Murphy USA: An Insightful Decade of Growth
- Oceana's SeaChange Event Surpasses $1.7 Million for Oceans
- Slide Insurance Prepares for Earnings Call with Investors
- Molina Healthcare Faces Investigation: What Investors Need to Know
- A Decade of Growth: Stride's Impressive Stock Journey
- NOV Inc. Highlights Growth Amidst Economic Challenges in 2025
- Live Oak Bancshares Announces New Depositary Share Offering Details
- Community Healthcare Earnings Report: Insights and Outlook
- Exploring Clearwater Paper's Upcoming Earnings Insights
- ConnectOne Bancorp: Analyzing Upcoming Earnings Announcement
- Tilray's Financial Report: Mixed Results with Promising Forecasts
- FIBRA Prologis Reveals Impressive Second Quarter Growth
- NOV Inc. Reports Impressive Q2 2025 Financial Performance
- Vice President JD Vance's Tour at Metallus Steel Plant
- Reddit, Inc. Investors May Join Securities Fraud Action
- Globe Life Receives Closure on DOJ Investigation, Focuses on Growth
- BCAN Offers Support to Deion Sanders Amid Cancer Battle
- Discover How Altria, Mastercard, and Ulta Can Build Your Wealth
- Live Oak Bancshares Announces New Depositary Share Offering
- Slide Insurance Holdings Set to Share Q2 Results Soon
- Earnings Anticipation for LendingClub: Key Insights Ahead
- Twin Hospitality Group's Exciting Financial Updates for Investors
- NexPoint Residential: What to Expect from Earnings Ahead
- Expectations for Teladoc Health's Upcoming Earnings Report
- Understanding Tetra Technologies: Prior Earnings and Future Prospects
- Insights on Expro Group Holdings' Quarterly Performance Ahead
- Understanding Okeanis Eco Tankers and Its Earnings Outlook
- Surge Energy Reports Strong Q2 Results: Production Forecast Up
- Grupo Comercial Chedraui Reports Strong Second Quarter Results
- Emerging Opportunities in Alpha-synuclein Inhibitors Market Growth
- FIBRA Prologis Reports Strong Q2 2025 Earnings Insights
- Key Insights for Investors Ahead of Meta Platforms Q2 Earnings
- Abercrombie & Fitch: An In-Depth Look at Its Value Prospects
- Strategic Decisions Following Bankruptcy: Nano Dimension Insights
- Qualigen Therapeutics Updates on Nasdaq Listing Compliance Efforts
- FAT Brands Set to Reveal Second Quarter Financial Insights
- Unlocking Long-Term Growth: The Journey of Texas Instruments
- Grupo Comercial Chedraui Reports Strong Second Quarter Performance
- Empowering Recovery: Join the Opioid Summit for Veterans
- Market Insights: Key Earnings Reports and Trends Ahead
- Understanding the Centene Corporation Class Action Lawsuit
- Understanding the Recent Legal Challenges Facing Reddit, Inc.
- Investors Rally Behind Hims & Hers Amid Class Action Lawsuit
- Brown & Brown, Inc. Reports Significant Growth in Q2 2025
- Investor Alert: Legal Action for Sarepta Therapeutics Losses
- Upcoming Earnings Call for Maravai LifeSciences: Key Insights
- Class Action Notice: Hims & Hers Investors Can Recover Losses
- Investors Alert: Hims & Hers Faces Class Action Lawsuit Risks
- Sarepta Therapeutics Facing Class Action Lawsuit Amid Concerns